Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517874) titled 'Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers' on April 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Amazentis SA
Condition:
Irritation/Irritant
Sensitisation
Intervention:
Other: Mitopure Topical Formula 11
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 1, 2026
Target Sample Size: 100
Countries of Recruitment:
United Kingdom
To know more, visit https://clin...